【ChiCTR2500113083】An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial

查看原文

立即下载

基本信息

登记号

ChiCTR2500113083

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2025-11-24

临床申请受理号

靶点

适应症

Patients with advanced disease with a need for end-of-life care

试验通俗题目

An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial

试验专业题目

An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

The study aims to examine the feasibility and acceptability of an evidence-based ACP programme among patients with advanced diseases in the Emergency Department. The objectives of the study are to determine the feasibility of conducting an ACP programme in the ED based on recruitment and attrition rate, to examine the acceptability of the intervention based on satisfaction survey and qualitative comments on patient’s experiences, and to examine the preliminary effect of the programme on patient reported ACP readiness and evidence of ACP documentation on medical record.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

其它

随机化

Eligible and consented patients will be randomised into intervention or control group in a 1:1 ratio using the Random Sequence Generator (Prachanukool et al., 2022).

盲法

Due to the nature of the intervention, the participants cannot be blinded to the group allocation. The outcome assessors will be blinded to the group allocation.

试验项目经费来源

None

试验范围

目标入组人数

实际入组人数

第一例入组时间

2025-11-24

试验终止时间

2026-10-25

是否属于一致性

入选标准

Subjects will be recruited from Emergency Medicine Wards, ED of two public hospitals in Kowloon West Cluster, Hong Kong. One of the ED is in Kwai Tsing District providing tertiary care while the other ED is located on Lantau Island providing tertiary and rehabilitation service.Participants are adult (18 years old or above) admitted to the EMW, Chinese-speaking, fulfill the two general and one clinical criterion stipulated in the Supportive and Palliative Care Indicator Tools (SPICT™) (The University of Edinburgh, 2025). SPICT was developed as an instrument to identify patients at risk of dying within one year (Paulik et al., 2024). It has a sensitivity of 0.65 (95% CI) and a specificity of 0.72 (95% CI) in detecting life-limiting conditions (Paulik et al., 2024).By using this dual indicators approach, it allows a more comprehensive and personalized model of care for patients with advanced illnesses (Paulik et al., 2024).；

排除标准

Patients will be excluded if they are mentally incompetent determined based on the Diagnostic assessment Confusion Assessment Method (3D-CAM) (Marcantonio et al., 2015). The Chinese version of 3D-CAM can be used as a reliable and accurate instrument for delirium assessment, its sensitivity ranges from 85.7 to 100% and the specificity from 95.7 to 96.4% (Mu et al., 2020). Patients who were non-Chinese speaking, non-communicable, refusal or unable to give consent, altered sensorium or cognitive functions, physical unwell to receive the intervention, and with previous documented ACP or AMD will be excluded from the study.；

研究者信息

研究负责人姓名

请登录查看

试验机构

The Nethersole School of Nursing, The Chinese University of Hong Kong

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看